Sulzer Medica IntraCoil Peripheral Stent Approved Despite Panel Reservations
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica's Intratherapeutics unit expects sales of the IntraCoil stent to double over the next year, following PMA approval April 8 for primary stenting of the femoral and popliteal arteries
You may also be interested in...
FDA Passes On Critical Limb Ischemia Laser; Spectranetics Ponders Options
Spectranetics hopes FDA will accept a retrospective analysis of bypass surgery data as a control arm to support a critical limb ischemia indication for its CVX-300 excimer laser catheter system in lieu of further clinical studies
FDA Passes On Critical Limb Ischemia Laser; Spectranetics Ponders Options
Spectranetics hopes FDA will accept a retrospective analysis of bypass surgery data as a control arm to support a critical limb ischemia indication for its CVX-300 excimer laser catheter system in lieu of further clinical studies
ev3 Expanding Vascular Presence Via $95 Mil. IntraTherapeutics Acquisition
Private equity investor Warburg Pincus' ev3, Inc. unit is looking to build its peripheral vascular disease business through the purchase of Centerpulse subsidiary IntraTherapeutics for $95 mil. cash